5d806030eb
- Applied reviewer-requested changes - Quality gate pass (fix-from-feedback) Pentagon-Agent: Auto-Fix <HEADLESS>
39 lines
No EOL
3.2 KiB
Markdown
39 lines
No EOL
3.2 KiB
Markdown
---
|
|
type: claim
|
|
title: CMS RADV audit validation
|
|
confidence: likely
|
|
description: The CMS Risk Adjustment Data Validation (RADV) audits have a 70% failure rate, indicating significant discrepancies in reported data.
|
|
created: 2026-01-00
|
|
processed_date: 2026-01-00
|
|
source: commonwealth-fund
|
|
relevant_notes: ["CMS 2027 chart review claim"]
|
|
challenged_by: []
|
|
---
|
|
|
|
The CMS Risk Adjustment Data Validation (RADV) audits have revealed a 70% failure rate in the data submitted by Medicare Advantage plans. This high failure rate suggests that there are significant discrepancies between the data reported by these plans and the actual data, which could impact the accuracy of risk adjustment payments.
|
|
|
|
The RADV audits are part of CMS's efforts to ensure the integrity of the Medicare Advantage program by validating the data used to calculate risk scores. These audits are separate from those conducted by the Office of Inspector General (OIG), which also reviews Medicare Advantage data but through different methodologies and objectives.
|
|
|
|
The 70% failure rate in RADV audits highlights the need for improved data accuracy and compliance among Medicare Advantage plans. This issue is particularly relevant in the context of ongoing policy discussions about the future of risk adjustment and the potential impact of proposed changes, such as the CMS 2027 chart review exclusion.
|
|
|
|
While the RADV audits predate the 2027 policy proposal, they provide important context for understanding the challenges and implications of proposed changes to the risk adjustment process. The audits underscore the importance of accurate data reporting and the potential financial implications for plans that fail to meet CMS's standards.
|
|
|
|
---
|
|
type: claim
|
|
title: V28 and chart review complementarity
|
|
confidence: likely
|
|
description: The V28 phase-in and chart review exclusion are complementary strategies in CMS's approach to risk adjustment, addressing different aspects of the process.
|
|
created: 2026-01-00
|
|
processed_date: 2026-01-00
|
|
source: commonwealth-fund
|
|
relevant_notes: []
|
|
challenged_by: []
|
|
---
|
|
|
|
The V28 phase-in and chart review exclusion represent complementary strategies in CMS's approach to risk adjustment for Medicare Advantage plans. While the V28 phase-in focuses on the methodology of calculating risk scores, the chart review exclusion addresses the data sources used in this calculation.
|
|
|
|
These strategies are orthogonal dimensions of CMS's risk adjustment policy, with V28 addressing the "how" of risk score calculation and chart review exclusion addressing the "what" of data inclusion. By tackling both the methodology and data sources, CMS aims to enhance the accuracy and fairness of risk adjustment payments.
|
|
|
|
However, industry stakeholders have raised concerns that the savings estimates from V28 and chart review exclusion may not be fully additive. Plans may adapt to one change in a way that reduces the impact of the other, potentially affecting the overall savings and effectiveness of these strategies.
|
|
|
|
Despite these concerns, the complementary nature of V28 and chart review exclusion reflects CMS's comprehensive approach to improving the risk adjustment process, ensuring that both the calculation methods and data sources are robust and reliable. |